Evidence map›Paper›PMID 18297573›Full record

ReviewThe journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians2008

Type 2 diabetes in pregnancy: exposing deceptive appearances.

Oded Langer

2 registry-linked trialsAbstract readReview
PubMed Publisher
In one paragraph

Review in The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 4 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05479214 phase4completedstarted 2022, after this paper: background citation

Effect of Adding Metformin to Insulin in Uncontrolled Diabetic Patients During the 3rd Trimester of Pregnancy on Glycemic Control, Fetal and Neonatal Outcomes ,Randomized Controlled Trial

Ran2022Enrolled150Registered outcomes8Posted comparisons0ConditionsDiabetes Mellitus PregnancyArmsInsulin, Metformin
Open the trial in the graph
NCT01474525 naunknown statusnot on this mapstarted 2010, after this paper: background citation

Managing Diabetes During Pregnancy in the Wireless Age: a RCT of Glucose Telemonitoring

TypeinterventionalSponsorSamuel Lunenfeld Research Institute, Mount Sinai HospitalRan2010 to 2012Enrolled100ConditionsGestational Diabetes Mellitus, Type 2 Diabetes MellitusArmsHome Blood Glucose Telemonitoring System
3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Management of gestational diabetes mellitus.Diabetes, metabolic syndrome and obesity : targets and therapy · 2009
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Oded LangerDepartment of Obstetrics and Gynecology, St. Luke's-Roosevelt Hospital Center, Columbia University, New York, NY 10019, USA. odlanger@chpnet.org

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Now that we have been forewarned of the growing pandemic of type 2 diabetes and obesity in pregnancy, we need to become forearmed. Over the past few decades there has been no significant improvement in perinatal outcome complicated by diabetes mellitus (type 1 and type 2). The recognition of modifiable risk factors such as maternal glycemic control using self-monitoring blood glucose in combination with pharmacological therapy (intensified therapy) and weight gain in pregnancy should enhance pregnancy outcome. The overemphasis and concentration on the non-modifiable risk factors in pregnancy is a futile pursuit that may generate lively discussion but paucity of results. The focus needs to be in education for the care provider, i.e., enhanced recognition of this growing entity and a heightened awareness of the need for pre-pregnancy counseling about preconception glycemic control. Another center of attention should be the dissemination of information to patients of the impending maternal and fetal risks of type 2 diabetes in pregnancy. This care would include antenatal care for surveillance of maternal diabetes complications as well as careful obstetric surveillance to improve maternal and fetal outcomes.

Indexed as

Prenatal CareDiabetes Mellitus, Type 2FemaleHumansHyperglycemiaHypoglycemic AgentsPreconception CarePregnancyPregnancy in DiabeticsPregnancy OutcomeHypoglycemic Agents

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.